Exact Sciences | EXAS - Gross Profit On Sales


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Exact Sciences

Exact Sciences reported $445.58M in Gross Profit on Sales for its fiscal quarter ending in March of 2023.


Gross Profit On Sales Change
Accelerate Diagnostics AXDX:US USD 1.01M 170K
Agilent A:US USD 924M 44M
Becton, Dickinson and Co. BDX:US USD 2.24B 102M
Bruker BRKR:US USD 359.7M 5.9M
Charles River Laboratories CRL:US USD 377.65M 21.23M
Danaher DHR:US USD 4.37B 569M
Exact Sciences EXAS:US USD 445.58M 39.74M
Hologic HOLX:US USD 585.8M 32.1M
Illumina ILMN:US USD 655M 17M
Mesa Laboratories MLAB:US USD 33.2M 436K
Myriad Genetics MYGN:US USD 122M 1.9M
NanoString Technologies NSTG:US USD 12.93M 366K
OraSure Technologies OSUR:US USD 65.85M 16.26M
Quidel QDEL:US USD 448.6M 400K
Repligen RGEN:US USD 100.82M 4.75M
STAAR Surgical STAA:US USD 57.56M 7.78M
Thermo Fisher Scientific TMO:US USD 4.27B 462M
Waters WAT:US USD 400.29M 110.03M